Carysil Limited: QIP Fund Utilization Report for Q1 FY27 Confirms No Material Deviation
Carysil Limited's QIP fund utilization report for Q1 FY27, issued by ICRA, shows no material deviation from the issue's objectives. The company utilized ₹87.86 crore out of ₹121.65 crore raised. Capital expenditure utilization is extended to March 31, 2027. Unutilized funds are in fixed deposits and planned for deployment.
The announcement is a routine monitoring agency report confirming fund utilization as per plan, with minor adjustments and an approved timeline extension. It does not introduce new material information that would significantly impact the company's stock or operations.
The report confirms no material deviation in fund utilization, which is a neutral outcome. While the delay in capital expenditure utilization is noted, it has been approved by the board.
CARYSIL LIMITED has submitted the Monitoring Agency Report for the utilization of funds raised through Qualified Institutions Placement (QIP) for the quarter ended June 30, 2026. The report, issued by ICRA Limited, confirms that there has been no material deviation in the utilization of QIP proceeds concerning the objects of the issue.
The QIP, initially sized at ₹125.00 crore, had net proceeds of ₹121.70 crore, later revised to ₹121.65 crore due to higher issue-related expenses. The funds were allocated to three main objectives: funding capital expenditure for machinery and facilities (₹62.50 crore), funding working capital requirements (₹31.25 crore), and general corporate purposes (₹27.90 crore).
As of June 30, 2026, a total of ₹87.86 crore had been utilized. Specifically, ₹36.04 crore was utilized for capital expenditure, ₹31.25 crore for working capital, and ₹27.90 crore for general corporate purposes. A total of ₹26.46 crore remained unutilized, with the company planning to deploy these funds in subsequent quarters. The report also noted a delay in the utilization of QIP proceeds earmarked for capital expenditure, with the timeline extended to March 31, 2027, as approved by the Board of Directors on March 20, 2026.
The report details the progress of each objective, including the amount utilized during the quarter and the total unutilized amount. The unutilized proceeds were primarily held in fixed deposits with HDFC Bank, earning interest rates between 6.25% and 6.45%. The company's cash credit accounts with Citi Bank and HDFC Bank showed a negative balance as of June 30, 2026, which management confirmed would be addressed through subsequent withdrawals.
What to do with a filing like this
CARYSIL LIMITED filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CARYSIL LIMITED. Read the original for the full detail.